THRV-1257

N/A

Report date: 2024/03/04 17:50:36
NME

Base Information

Drug NameTHRV-1257
Drug Alias NameTHRV-1257THRYV-1257
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Sgk1 inhibitorsIon channels modulators
TargetsSerine/threonine-protein kinase Sgk1Ion channels
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsBreast Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThryv Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesThryv Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsThyroid Carcinoma, Anaplastic
Inactive IndicationsBreast NeoplasmsLymphoma, B-CellNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A